CN Patent

CN104558036A — 一种替诺福韦艾拉酚胺半反丁烯二酸盐晶型及其制备方法

Assigned to Hangzhou Heze Pharmaceutical Technology Co Ltd · Expires 2015-04-29 · 11y expired

What this patent protects

本发明公开了一种替诺福韦艾拉酚胺半反丁烯二酸盐晶型及其制备方法，所述替诺福韦艾拉酚胺半反丁烯二酸盐晶型使用Cu-Kα辐射，所述晶型的X射线粉末衍射在以下2θ角度位置具有特征峰：7.4±0.2°、8.6±0.2°、11.2±0.2°、19.5±0.2°和21.3±0.2°。本发明制得了一种新的替诺福韦艾拉酚胺半反丁烯二酸盐晶型，制备简单，晶型稳定，适合工业化生产。

USPTO Abstract

本发明公开了一种替诺福韦艾拉酚胺半反丁烯二酸盐晶型及其制备方法，所述替诺福韦艾拉酚胺半反丁烯二酸盐晶型使用Cu-Kα辐射，所述晶型的X射线粉末衍射在以下2θ角度位置具有特征峰：7.4±0.2°、8.6±0.2°、11.2±0.2°、19.5±0.2°和21.3±0.2°。本发明制得了一种新的替诺福韦艾拉酚胺半反丁烯二酸盐晶型，制备简单，晶型稳定，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN104558036A
Jurisdiction
CN
Classification
—
Expires
2015-04-29
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Heze Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.